Addex Ptb Ratio from 2010 to 2024

ADXN Stock  USD 7.98  0.31  3.74%   
Addex Therapeutics PTB Ratio yearly trend continues to be very stable with very little volatility. PTB Ratio is likely to grow to 346.47 this year. PTB Ratio is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on Addex Therapeutics' equity relative to its net asset value. View All Fundamentals
 
PTB Ratio  
First Reported
2010-12-31
Previous Quarter
329.9734759
Current Value
346.47
Quarterly Volatility
217.88831624
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Addex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Addex Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 290.7 K, Interest Expense of 20.5 K or Total Revenue of 2.7 M, as well as many indicators such as Price To Sales Ratio of 223, Dividend Yield of 0.0 or PTB Ratio of 346. Addex financial statements analysis is a perfect complement when working with Addex Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Addex Therapeutics Correlation against competitors.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Latest Addex Therapeutics' Ptb Ratio Growth Pattern

Below is the plot of the Ptb Ratio of Addex Therapeutics over the last few years. It is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value. Addex Therapeutics' PTB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Addex Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Ptb Ratio10 Years Trend
Slightly volatile
   Ptb Ratio   
       Timeline  

Addex Ptb Ratio Regression Statistics

Arithmetic Mean171.95
Geometric Mean42.04
Coefficient Of Variation126.72
Mean Deviation166.88
Median94.50
Standard Deviation217.89
Sample Variance47,475
Range770
R-Value0.43
Mean Square Error41,667
R-Squared0.19
Significance0.11
Slope20.96
Total Sum of Squares664,654

Addex Ptb Ratio History

2024 346.47
2023 329.97
2022 107.09
2021 231.12
2020 433.44
2019 14.52
2018 8.47

About Addex Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Addex Therapeutics income statement, its balance sheet, and the statement of cash flows. Addex Therapeutics investors use historical funamental indicators, such as Addex Therapeutics's Ptb Ratio, to determine how well the company is positioned to perform in the future. Although Addex Therapeutics investors may use each financial statement separately, they are all related. The changes in Addex Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Addex Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Addex Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Addex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
PTB Ratio 329.97  346.47 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Addex Stock

When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out the analysis of Addex Therapeutics Correlation against competitors.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(18.99)
Revenue Per Share
2.04
Quarterly Revenue Growth
(0.53)
Return On Assets
(1.26)
Return On Equity
(8.10)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.